Request for Proposals: Pfizer Independent Medical Education Grant (Saudi Arabia)

Pfizer is offering a competitive grant program aimed at enhancing the education of healthcare professionals (HCPs) in the management of hemophilia in Saudi Arabia. This initiative seeks to address educational gaps and improve clinical practices related to hemophilia. Eligible organizations are invited to submit proposals by 15 December 2026.

Opportunity at a Glance:

- Provider: Pfizer International LLC

- Opportunity Type: Competitive Grant for Independent Medical Education

- Funding Amount: Up to 187,500 SAR per project

- Eligible Applicants: Healthcare institutions, professional organizations, medical education companies

- Geographic Scope: Saudi Arabia

- Deadline: 15 December 2026

- Project Duration: Up to 12 months

About the Opportunity

The grant program is designed to support projects that enhance HCPs’ knowledge, competencies, and clinical practices concerning hemophilia management. The goal is to improve the timely recognition, diagnosis, and management of hemophilia, addressing barriers such as limited awareness and inconsistent referral pathways.

Funding and Benefits:

- Financial Support: Projects can receive funding up to 187,500 SAR. The total available budget for this RFP is 187,500 SAR.

- Eligible Costs: Includes direct costs, institutional overhead costs (capped at 28%), and indirect costs.

Who Is Eligible?:

- Eligible Applicants: Medical, dental, nursing, allied health, and pharmacy schools; healthcare institutions; professional organizations; medical societies; and medical education companies.

- Geographic Focus: Projects must be based in Saudi Arabia.

- Organizational Requirements: Only organizations, not individuals or unaffiliated medical practice groups, are eligible. The organization must be legally able to receive funding from Pfizer.

Eligible Activities or Priority Areas:

- Educational Strategies: Programs to increase HCP awareness of hemophilia treatment guidelines.

- Resource Development: Tailored educational resources for various HCP types.

- Innovative Tools: Development of tools to enhance HCP understanding of treatment pathways.

- Exclusions: Projects primarily targeting patients or the general public are not eligible.

Why This Opportunity Matters:

This grant addresses the critical need for improved healthcare professional education in hemophilia management in Saudi Arabia. By supporting initiatives that enhance clinical practices, the program aims to reduce the risk of complications and improve patient outcomes in the region.

How to Apply:

- Access the Application Form: Visit the Pfizer Grant Portal.

- Create an Account: First-time users should create an account on the Requester Portal.

- Select the Program: Navigate to ‘Grant Programs’, choose ‘Medical Education’, and apply for the 2027 RD KSA Hemophilia Management IME.

- Complete the Application: Fill out all required sections and upload the proposal in the specified format.

- Submit by Deadline: Ensure submission by 23:59 EST, 15 December 2026.

Frequently Asked Questions:

What is the maximum funding available for a project? Projects can request funding up to 187,500 SAR. Who can apply for this grant? Eligible applicants include healthcare institutions, professional organizations, and medical education companies based in Saudi Arabia. What is the deadline for submission? The submission deadline is 15 December 2026. Where can I submit my application? Applications should be submitted via the Pfizer Grant Portal. What types of projects are excluded? Projects focusing on clinical research or those primarily targeting patients or the general public are not eligible.

Next Steps:

Eligible organizations are encouraged to review the official guidelines and prepare their proposals in alignment with the RFP requirements. Ensure all application components are complete and submitted by the deadline to be considered for funding. For more information, visit Pfizer International LLC.